Physicians Realty Trust Director Richard A. Weiss Buys 1,000 Shares (DOC)
Physicians Realty Trust (NYSE:DOC) Director Richard A. Weiss acquired 1,000 shares of the stock in a transaction that occurred on Monday, June 2nd. The stock was purchased at an average cost of $13.88 per share, with a total value of $13,880.00. Following the completion of the acquisition, the director now directly owns 14,151 shares in the company, valued at approximately $196,416. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link.
Several analysts have recently commented on the stock. Analysts at Bank of America initiated coverage on shares of Physicians Realty Trust in a research note on Monday. They set a “buy” rating and a $14.25 price target on the stock. Analysts at Wunderlich raised their price target on shares of Physicians Realty Trust from $14.75 to $15.50 in a research note on Wednesday, May 21st. They now have a “buy” rating on the stock. Two research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Physicians Realty Trust currently has a consensus rating of “Buy” and an average target price of $15.03.
Shares of Physicians Realty Trust (NYSE:DOC) traded up 0.36% on Monday, hitting $13.86. The stock had a trading volume of 371,985 shares. Physicians Realty Trust has a 52 week low of $11.00 and a 52 week high of $14.00. The stock’s 50-day moving average is $13.30 and its 200-day moving average is $12.88. The company’s market cap is $295.2 million.
Physicians Realty Trust (NYSE:DOC) last announced its earnings results on Wednesday, May 7th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by $0.05. Analysts expect that Physicians Realty Trust will post $0.88 EPS for the current fiscal year.
Physicians Realty Trust is a real estate investment trust (NYSE:DOC).
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.